ST2 PATHOBIOLOGY
A comprehensive review of the complex interleukin (IL)-33/ST2 pathway is beyond the scope of this editorial and may be found elsewhere (6) . Briefly, ST2 is a member of the IL-1 family of proteins. Through alternative splicing, ST2 is found in multiple isoforms, including a transmembrane form (ST2 ligand, or ST2L) and a soluble, circulating form (ST2) (6) . In >35 ng/ml (19) . These studies provide a roadmap for future clinical trials of ST2-guided therapy.
Based on the strength of evidence, we argue the time is right for investigators to perform welldesigned, prospective, international, multicenter trials of ST2-guided HF care to obtain actionable data in a timely fashion. It is imperative to avoid the mistakes made in NP-guided trials: multiple small, underpowered studies with variable endpoints is the wrong way to spend limited research resources, and an approach that may slow the move toward CV precision medicine. Bayés-Genís et al.
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